The efficacy and safety of combination bronchodilator therapy

European Respiratory Review

Volumn 6, Issue 39, 1996, Pages 286-289

  Wilson, J D ^a   Serby, C W ^a   Menjoge, S S ^a   Witek T J , Jr ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Chronic obstructive pulmonary disease; Clinical trial; Ipratropium bromide; Pulmonary function; Salbutamol sulphate

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; MUSCARINIC RECEPTOR BLOCKING AGENT; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; AGED; AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; VITAL CAPACITY;

EID: 0030455340     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)